Neurofibroma

What it is

From: Orphanet

A rare benign peripheral nerve sheath tumor characterized by a well-demarcated intraneural or diffusely infiltrative extraneural space-occupying lesion consisting of Schwann cells, perineurial-like cells, and fibroblasts. It presents as a cutaneous nodule, a circumscribed mass in a peripheral nerve, a plexiform enlargement of a major nerve trunk, or with diffuse but localized involvement of skin and subcutaneous tissue. Multiple neurofibromas are typically associated with neurofibromatosis 1. Malignant transformation occurs almost exclusively in plexiform neurofibromas and neurofibromas of major nerves.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Neurofibromas · Obligate (100%)

A benign peripheral nerve sheath tumor that generally appears as a soft, skin-colored papule or small subcutaneous nodule. Individuals with neurofibromatosis can have numerous neurofibromas.

Enlarged peripheral nerve · Frequent (79-30%)

Increase in size of a peripheral nerve. This finding can be appreciated by palpation along the axis of the nerve.

Periarticular subcutaneous nodules · Frequent (79-30%)

Subcutaneous nodules that are located in the vicinity of joints.

Plexiform neurofibroma · Frequent (79-30%)

A neurofibroma in which Schwann cells proliferate inside the nerve sheath, producing an irregularly thickened, distorted, tortuous structure.

Subcutaneous neurofibromas · Frequent (79-30%)

A neurofibroma (benign peripheral nerve sheath tumor) localized in the subcutis (subcutaneous region).

Abnormal cranial nerve morphology · Occasional (29-5%)

Structural abnormality affecting one or more of the cranial nerves, which emerge directly from the brain stem.

Paraspinal neurofibromas · Occasional (29-5%)

A neurofibroma (benign peripheral nerve sheath tumor) localized adjacent to the spine.

Spinal canal stenosis · Occasional (29-5%)

An abnormal narrowing of the spinal canal.

Spinal neurofibromas · Occasional (29-5%)

A neurofibroma (benign peripheral nerve sheath tumor) localized in the spine.

Symmetric spinal nerve root neurofibromas · Occasional (29-5%)

Multiple neurofibromas of the spinal nerve roots with a symmetric distribution.

Peripheral nerve compression · Occasional (29-5%)

Abnormal biliary tract morphology · Very rare (<4-1%)

A structural abnormality of the biliary tree.

Enlargement of parotid gland · Very rare (<4-1%)

Increased size of the parotid gland.

Facial neoplasm · Very rare (<4-1%)

A tumor (abnormal growth of tissue) of the face.

Other findings in the same source

From: Orphanet

Additional reported features include Intestinal bleeding (Very rare (<4-1%)); Kyphoscoliosis (Very rare (<4-1%)); Macrocephaly (Very rare (<4-1%)); Neoplasm of the breast (Very rare (<4-1%)); Neoplasm of the trachea (Very rare (<4-1%)); Palmar neurofibromas (Very rare (<4-1%)); Peripheral schwannoma (Very rare (<4-1%)); Recurrent otitis media (Very rare (<4-1%)); Atypical neurofibromatosis (Very rare (<4-1%)); Multiple intestinal neurofibromatosis (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Adult

Which doctor should you see?

The suggested department for discussing Neurofibroma is Oncology, with a oncologist and relevant organ specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Relevant organ specialist / Surgical Oncology as indicated.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Has the exact tumour type been confirmed, and is staging relevant?
• What is the goal of each proposed treatment option?
• How will side effects, daily function and supportive care be addressed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Neurofibroma. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.